D.E. Shaw & Co
NEOS

D.E. Shaw & Co’s Neos Therapeutics, Inc NEOS Stock Holding History

D.E. Shaw & Co’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,653
Closed -$28K – 4256
2019
Q3 		$28K Sell
18,653
-25,253
-58% -$40.9K ﹤0.01% 3751
2019
Q2 		$57K Buy
+43,906
New +$80.8K ﹤0.01% 3582

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co's NEOS Position: Q4 2019 in Review

D.E. Shaw & Co sold out of Neos Therapeutics, Inc (NEOS) in Q4 2019, closing a stake of 18,653 shares — an estimated $28K sold.

D.E. Shaw & Co first reported a position in NEOS in Q2 2019 and held it in 2 quarters. The position peaked at $57K in Q2 2019. 54 funds tracked by Wall St. Rank hold NEOS as of Q4 2019.

  • D.E. Shaw & Co reported no remaining Neos Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 18,653 Neos Therapeutics, Inc shares in Q4 2019, an estimated $28K.
  • D.E. Shaw & Co first reported a position in Neos Therapeutics, Inc in Q2 2019 and held it in 2 quarters.
  • D.E. Shaw & Co's Neos Therapeutics, Inc position peaked at $57K in Q2 2019.
  • 54 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.